Femara (letrozole) to prevent recurrent breast cancer

November 2003

You'll see more women taking Femara (letrozole) to prevent recurrent breast cancer.

Tamoxifen is the standard of care for hormone-receptor-positive breast cancer. Taking it for 5 years reduces the risk of recurrence by 47% and improves survival.

But after 5 years tamoxifen's benefits wane.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote